Mundipharma International Limited - Strategic SWOT Analysis Review

GlobalData
February 6, 2012
27 Pages - SKU: GBDT6797859
License type:
Table of Contents Search inside this report Related Reports
Mundipharma International Limited - Strategic SWOT Analysis Review

Summary

Mundipharma International Limited (Mundipharma) is a bio-pharmaceutical company engaged in the research and development, manufacturing and commercialization of drugs for the treatment of cancer, heart diseases and pain management. It mainly focuses on cardiovascular, oncology, respiratory and analgesics therapeutical areas. Geographically, the company has its presence in more than 33 European countries with opeartions throughout the world. The company has its manufacturing and R&D facilities in the US, the UK, Canada and Germany. It also established its operations in India, China, Latin America and Cyprus through joint ventures.

The company's key business strategies include main focus on to search out innovative treatment options and to support the education of healthcare professionals for the benefit of patients. It has entered into a strategic collaboration agreement with Allos Therapeutics, Inc., to co-develop FOLOTYN® (pralatrexate injection). Mundipharma is headquartered in Cambridge, the UK.

Mundipharma International Limited Key Recent Developments

Aug 23, 2011: Acino Reaches Settlement In Oxycodone Patent Dispute

GlobalData’s Mundipharma International Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Pharmaceuticals Company Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!